Adverum Biotechnologies, Inc.
VARIANT AAV CAPSIDS FOR INTRAVITREAL DELIVERY
Last updated:
Abstract:
Provided are variant adeno-associated virus (AAV) capsid proteins and recombinant AAV virions having one or more variant AAV capsid proteins. Also provided are compositions and methods for the use of the recombinant AAV virions, such as for the treatment or prophylaxis of a disease or disorder.
Status:
Application
Type:
Utility
Filling date:
24 Apr 2020
Issue date:
29 Oct 2020